Targeting Inflammation–Oxidative Stress Crosstalk: Advances and Challenges in Nanocarrier-Based Interventional Strategies for Pulmonary Arterial Hypertension
Abstract Pulmonary arterial hypertension (PAH) is a cardiovascular disease characterized by a hidden or insidious onset with symptoms including dyspnea and heart failure, which can result in sudden death. Inflammation and oxidative stress are key factors in the pathogenesis of PAH. Hence, anti-inflammatory and antioxid...